Fatal intracranial haemorrhage associated with the administration of low-molecular-weight-heparin in a child

European Journal of Pediatrics

Volumn 164, Issue 9, 2005, Pages 589-590

  Van Heerde, Marc ^a   Sturkenboom, Marieke G G ^a   Zweegman, Sonja ^a   Labadie, Jerry ^b   Plötz, Frans B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Stichting Lareb   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING; BRAIN DEATH; BRAIN HEMORRHAGE; BRAIN RADIOGRAPHY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG FATALITY; ECHOCARDIOGRAPHY; ENDOCARDITIS; HEMOSTASIS; HUMAN; MALE; MEDICAL ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT WITHDRAWAL;

ANTICOAGULANTS; ECHOCARDIOGRAPHY; FATAL OUTCOME; HEART ATRIA; HEART DISEASES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFANT; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRACRANIAL HEMORRHAGES; MALE; THROMBOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 24044521637     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-005-1685-0     Document Type: Article

References (9)

1. Dix D, Andrew M, Marzinotto V, Charpentier K, Bridge S, Monagle P, deVeber G, Leaker M, Chan AK, Massicotte MP (2000) The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr 136: 439-445
2. Ferro JM (2003) Cardioembolic stroke: an update. Lancet Neurol 2: 177-188
3. Guyatt G, Schunemann HJ, Cook D, Jaeschke R, Pauker S (2004) Applying the grades of recommendation for antithrombotic and thrombolytic therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 179S-187S
4. Kavanagh D (2004) Life threatening haemorrhagic events associated with the administration of low-molecular-weight-heparin. Thromb Haemost 91: 833-834
5. Massicotte P, Adams M, Marzinotto V, Brooker LA, Andrew M (1996) Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 128: 313-318
6. Massicotte P, Julian JA, Gent M, Shields K, Marzinotto V, Szechtman B, Andrew M (2003) An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thromb Res 109: 85-92
7. Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD (2004) Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 645S-687S
8. Piquet P, Laporte-Simitsidis S, Mismetti P, Doubine S, Decousus H (2001) Nadroparin (Fraxiparin) in paediatrics. Dosage nomogram validation after cardiac surgery (abstract). Thromb Haemost P2325
9. Tornos P, Almirante B, Mirabet S, Permanyer G, Pahissa A, Soler-Soler J (1999) Infective endocarditis due to Staphylococcus aureus - deleterious effect of anticoagulant therapy. Arch Intern Med 159: 473-475